MDT Medtronic
NYSE · SEC CIK 1613103 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $8.92M 5 sales by 3 insiders
- Filings on record
- 247 since 2021-08-04, latest 2026-09-17 16:17
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| KIIL HARRY SKIP | EVP, Pres Cardiovascular | — | $5.61M |
| Smith Gregory L | EVP Gbl Ops, Supply Chain | — | $3.06M |
| Walter Matthew R. | SVP, Chief HR Off | — | $257.9K |
| Thompson Kweli | EVP, Pres, Neuroscience | — | — |
| Lee Joon Sup | Dir | — | — |
| Blomquist Denise L. | CAO | — | — |
| Pieton Thierry | EVP, CFO | — | — |
| Marinaro Michael | EVP, Pres MedSurg, Americas | — | — |
| Quinn Michelle | EVP, GC, Sec | — | — |
| Lewis Gregory P | Dir | — | — |
Transactions 342
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-16 | 2021-12-15 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | F - Tax | $104.94 | -89 | 33.1K | -0.3% | -$9,340 | |
| MI | 2021-12-07 | 2021-12-06 | MDT | PARKHILL KAREN L | EVP, CFO | G - Gift | $0.00 | 0 | 49.9K | New | $0 |
| 2021-12-07 | 2021-12-06 | MDT | PARKHILL KAREN L | EVP, CFO | S - Sale | $110.00 | -682 | 35.4K | -2% | -$75.0K | |
| 2021-11-09 | 2021-11-05 | MDT | Wall Brett A. | EVP, Pres Neuroscience | F - Tax | $122.98 | -238 | 25.3K | -0.9% | -$29.3K | |
| 2021-11-09 | 2021-11-05 | MDT | Liddicoat John R | EVP, Pres of Americas | F - Tax | $122.98 | -139 | 43.0K | -0.3% | -$17.1K | |
| 2021-11-09 | 2021-11-05 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | F - Tax | $122.98 | -245 | 33.2K | -0.7% | -$30.1K | |
| 2021-11-09 | 2021-11-05 | MDT | Kuntz Richard | SVP, Chief Medical, Science | F - Tax | $122.98 | -209 | 74.9K | -0.3% | -$25.7K | |
| 2021-11-09 | 2021-11-05 | MDT | Lerman Bradley E | SVP GC, Corp Sec | F - Tax | $122.98 | -250 | 48.6K | -0.5% | -$30.7K | |
| 2021-11-09 | 2021-11-05 | MDT | WHITE ROBERT JOHN | EVP, Pres. Medical Surgical | F - Tax | $122.98 | -246 | 46.6K | -0.5% | -$30.3K | |
| D | 2021-11-03 | 2021-11-01 | MDT | TEN HOEDT ROB | EVP, Pres EMEA | A - Grant | $0.00 | +832 | 45.4K | +2% | $0 |
| MI | 2021-10-14 | 2021-10-06+ | MDT | PARKHILL KAREN L | EVP, CFO | G - Gift | $0.00 | +49.9K | 49.9K | New | $0 |
| M | 2021-10-14 | 2021-10-06+ | MDT | PARKHILL KAREN L | EVP, CFO | G - Gift | $0.00 | -49.9K | 48.0K | -51% | $0 |
| D | 2021-10-01 | 2021-09-30 | MDT | Lerman Bradley E | SVP GC, Corp Sec | M - OptEx | $78.00 | +49.1K | 97.9K | +101% | +$3.83M |
| D | 2021-10-01 | 2021-09-30 | MDT | Lerman Bradley E | SVP GC, Corp Sec | S - Sale+OE | $126.58 | -49.1K | 48.8K | -50% | -$6.22M |
| D | 2021-09-01 | 2021-08-31 | MDT | Lerman Bradley E | SVP GC, Corp Sec | M - OptEx | $74.84 | +50.8K | 99.5K | +104% | +$3.80M |
| D | 2021-09-01 | 2021-08-31 | MDT | Lerman Bradley E | SVP GC, Corp Sec | S - Sale+OE | $134.17 | -50.8K | 48.8K | -51% | -$6.81M |
| DM | 2021-08-26 | 2021-08-25 | MDT | Martha Geoffrey | CEO, Dir | S - Sale+OE | $132.67 | -11.6K | 95.8K | -11% | -$1.54M |
| DM | 2021-08-26 | 2021-08-25 | MDT | Martha Geoffrey | CEO, Dir | M - OptEx | $61.81 | +11.6K | 97.3K | +14% | +$715.8K |
| DM | 2021-08-26 | 2021-08-25 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | S - Sale+OE | $134.08 | -28.4K | 33.3K | -46% | -$3.81M |
| DM | 2021-08-26 | 2021-08-25 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | M - OptEx | $38.71 | +28.4K | 40.6K | +233% | +$1.10M |
| D | 2021-08-04 | 2021-08-02 | MDT | Liddicoat John R | EVP, Pres of Americas | A - Grant | $0.00 | +3,353 | 42.8K | +8% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Liddicoat John R | EVP, Pres of Americas | F - Tax | $131.31 | -3,258 | 39.5K | -8% | -$427.8K |
| D | 2021-08-04 | 2021-08-02 | MDT | TEN HOEDT ROB | EVP, Pres EMEA | A - Grant | $0.00 | +4,419 | 44.5K | +11% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | TEN HOEDT ROB | EVP, Pres EMEA | F - Tax | $131.31 | -3,908 | 40.1K | -9% | -$513.2K |
| D | 2021-08-04 | 2021-08-02 | MDT | Kuntz Richard | SVP, Chief Medical, Science | A - Grant | $0.00 | +5,029 | 74.9K | +7% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Kuntz Richard | SVP, Chief Medical, Science | F - Tax | $131.31 | -4,905 | 69.9K | -7% | -$644.1K |
| D | 2021-08-04 | 2021-08-02 | MDT | Surface Carol A | SVP, Chief HR Off | A - Grant | $0.00 | +3,657 | 34.3K | +12% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Surface Carol A | SVP, Chief HR Off | F - Tax | $131.31 | -3,997 | 30.7K | -12% | -$524.8K |
| D | 2021-08-04 | 2021-08-02 | MDT | PARKHILL KAREN L | EVP, CFO | A - Grant | $0.00 | +7,162 | 85.8K | +9% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | PARKHILL KAREN L | EVP, CFO | F - Tax | $131.31 | -6,839 | 78.7K | -8% | -$898.0K |
| D | 2021-08-04 | 2021-08-02 | MDT | WHITE ROBERT JOHN | EVP, Pres. Medical Surgical | F - Tax | $131.31 | -4,897 | 40.7K | -11% | -$643.0K |
| D | 2021-08-04 | 2021-08-02 | MDT | WHITE ROBERT JOHN | EVP, Pres. Medical Surgical | A - Grant | $0.00 | +6,095 | 46.8K | +15% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Kirk Jennifer M | CAO | A - Grant | $0.00 | +1,143 | 8,387 | +16% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Wall Brett A. | EVP, Pres Neuroscience | F - Tax | $131.31 | -1,482 | 20.1K | -7% | -$194.6K |
| D | 2021-08-04 | 2021-08-02 | MDT | Wall Brett A. | EVP, Pres Neuroscience | A - Grant | $0.00 | +5,333 | 25.4K | +27% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Lerman Bradley E | SVP GC, Corp Sec | F - Tax | $131.31 | -5,450 | 42.7K | -11% | -$715.6K |
| D | 2021-08-04 | 2021-08-02 | MDT | Lerman Bradley E | SVP GC, Corp Sec | S - Sale | $131.52 | -4,000 | 48.2K | -8% | -$526.1K |
| D | 2021-08-04 | 2021-08-02 | MDT | Lerman Bradley E | SVP GC, Corp Sec | A - Grant | $0.00 | +6,019 | 48.8K | +14% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Martha Geoffrey | CEO, Dir | F - Tax | $131.31 | -5,450 | 76.8K | -7% | -$715.6K |
| D | 2021-08-04 | 2021-08-02 | MDT | Martha Geoffrey | CEO, Dir | A - Grant | $0.00 | +19.0K | 95.8K | +25% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | A - Grant | $0.00 | +5,486 | 33.3K | +20% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Salmon Sean | EVP, Pres Diabetes, Cardiovasc | F - Tax | $131.31 | -2,272 | 27.8K | -8% | -$298.3K |
Purchase Sale Sale after option exercise All abbreviations